Skip to main content

Blanca Borras Bermejo

Institutions of which they are part

Predoctoral researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Blanca Borras Bermejo

Institutions of which they are part

Predoctoral researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Projects

Caracterización de las infecciones y de su impacto en pacientes con Esclerosis Múltiple en la era de los tratamientos inmunosupresores de alta eficacia

IP: Susana Otero Romero
Collaborators: Imane Boutitah Benyaich, Enrique Rodríguez Zafra, Blanca Borras Bermejo, Anna Falcó Roget, Mar Tintore Subirana, Ana Zabalza de Torres, Daniel Romero Herrero
Funding agency: Instituto de Salud Carlos III
Funding: 115000
Reference: PI23/01654
Duration: 01/01/2024 - 31/12/2026

Asymptomatic SARS-CoV-2 infection in nursing homes

IP: Blanca Borras Bermejo
Collaborators: -
Funding agency: Institut Català de la Salut
Funding: 0.01
Reference: ICS/ARTICLE_RESIDENT/2021/BORRAS
Duration: 28/06/2021 - 28/06/2021

Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos.

IP: Lluis Armadans Gil
Collaborators: Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en, Blanca Borras Bermejo, Rosa Lopez Martinez , Laia Pinos Tella, Alexandre Martínez Marti
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: PI18/01887
Duration: 01/01/2019 - 30/06/2023

Virus Respiratorio Sincitial (VRS). Estudio de las características del virus, del huésped, y los factores ambientales como determinantes de la epidemia y su gravedad clínica.

IP: Tomàs Pumarola Suñé
Collaborators: Virus Respiratorio Sincitial (VRS). Estudio de las características del virus, del huésped, y los factores ambientales como deter, Blanca Borras Bermejo, Andres Antón Pagarolas, Carlos Rodrigo Gonzalo de Liria, Jorgina Vila Soler
Funding agency: Instituto de Salud Carlos III
Funding: 93170
Reference: PI18/00685
Duration: 01/01/2019 - 31/10/2022

Related news

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

The Lancet Neurology publishes the new criteria, the result of a global expert consensus led by Dr Xavier Montalban.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Maria Garcia Carrasco

Maria Garcia Carrasco

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Marta Comas Martinez

Marta Comas Martinez

Research technician
Read more
Mario Marotta Baleriola

Mario Marotta Baleriola

Senior researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Macarena Simon-Talero Horga

Macarena Simon-Talero Horga

Main researcher
Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.